黑色素瘤免疫治疗中的树突状细胞。
Dendritic cells in melanoma immunotherapy.
作者信息
Faries Mark B, Czerniecki Brian J
机构信息
Department of Surgery, University of Pennsylvania, 4 Silverstein, 3400 Spruce St., Philadelphia, PA 19104, USA.
出版信息
Curr Treat Options Oncol. 2005 May;6(3):175-84. doi: 10.1007/s11864-005-0001-6.
PMID:15869729
Abstract
No consensus exists regarding optimal systemic treatment for melanoma in the adjuvant or metastatic disease setting. Dendritic cell vaccine therapy, though investigational at present, offers very promising preliminary data that warrant exploration, and patients with existing disease and those seeking adjuvant treatment should evaluate open protocols using this strategy.
摘要
对于黑色素瘤在辅助治疗或转移性疾病背景下的最佳全身治疗方案，目前尚无共识。树突状细胞疫苗疗法虽然目前仍处于研究阶段，但已提供了非常有前景的初步数据，值得探索，患有现有疾病的患者以及寻求辅助治疗的患者应评估采用该策略的开放试验方案。
Zotero 插件